EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

Reducing blood loss so that bloodless surgery through minimally invasive incisions can be performed may help minimize morbidity and recovery period. Thus, hemostats, sealants are becoming a more important element of surgical practice, thereby, proliferating the hemostasis and tissue sealing agents market especially in the technologically advanced European region.

EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

Europe Hemostats and Tissue Sealants Market by Products (Topical Hemostat (Mechanical Hemostats, Active Hemostats, Flowable Hemostats) Adhesive and Tissue Sealants (Synthetic Tissue Sealant, Oxidized Regenerated Cellulose, Cyanoacrylate Adhesives, Other Synthetic Tissue Sealants) Natural Tissue Sealant( Chitin and Chitosan Based Hemostatic Agent, Other Natural Tissue Sealant, Adhesion Barrier Products & by Geography.

Request free sample

Reducing blood loss so that bloodless surgery through minimally invasive incisions can be performed may help minimize morbidity and recovery period. Thus, hemostats, sealants are becoming a more important element of surgical practice, thereby, proliferating the hemostasis and tissue sealing agents market especially in the technologically advanced European region. The United Kingdom, Germany, France, Italy, Spain & Rest of Europe are the countries whose market majorly accounts for the trade and manufacturing of these agents in the European region. The Europe hemostats and tissue sealants market is growing at 7.46% CAGR during the forecast period.

Europe has the second largest regional market for hemostats and sealants products. A few reasons can be attributed to this development. With increasing cases of chronic conditions, the volume of surgical procedures is also expected to increase, where the use of the tissue sealing agents are preferred to reduce the risk of blood loss. Germany has the largest market for hemostats and tissue sealants as the country has seen a substantial rise in its population of older adults and there has been the systematic launch of new devices. The penetration of these products would increase and drive the growth of the market if they are utilized for multiple conditions also.

Integra Lifesciences Corp., Advanced Medical Solutions (AMS) Group PLC, C.R. Bard, Inc., Baxter International Inc., B.Braun Melsungen AG, Cohera Medical Inc., Cryolife Inc., CSL Behring, Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Johnson & Johnson, Medtronic PLC, Pfizer, Inc. and Smith & Nephew PLC are the market players that operate through many sectors of the healthcare industry to invest in the hemostats and tissue sealants market.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
      • SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
      • INCREASING INCIDENCE OF CHRONIC DISEASES
      • INCREASE IN AGING POPULATION
      • INCREASE IN NUMBER OF SURGERIES
    • MARKET RESTRAINTS
      • STRINGENT REGULATIONS
      • ADVERSE REACTIONS AND COMPLICATIONS
    • MARKET OPPORTUNITIES
      • USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
      • ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
    • MARKET CHALLENGES
      • LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
      • PRODUCT SIDE EFFECTS AND FDA SCRUTINY
  1. MARKET BY PRODUCTS
    • TOPICAL HEMOSTAT
      • MECHANICAL HEMOSTATS
      • ACTIVE HEMOSTATS
      • FLOWABLE HEMOSTATS
    • ADHESIVE AND TISSUE SEALANTS
      • SYNTHETIC TISSUE SEALANT
        • OXIDIZED REGENERATED CELLULOSE
        • CYANOACRYLATE ADHESIVES
        • OTHER SYNTHETIC TISSUE SEALANTS
      • NATURAL TISSUE SEALANT
        • CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
        • OTHER NATURAL TISSUE SEALANT
      • ADHESION BARRIER PRODUCTS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SWOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
      • POLITICAL & LEGAL
      • ECONOMIC
      • TECHNOLOGICAL
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • BAXTER INTERNATIONAL INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BRAUN MELSUNGEN AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • COHERA MEDICAL INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • R. BARD, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CRYOLIFE INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • CSL BEHRING
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • INTEGRA LIFESCIENCES CORP
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JOHNSON AND JOHNSON
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MEDTRONIC PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SMITH AND NEPHEW PLC
        • MARKET OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • ZIMMER BIOMET HOLDINGS INC
        • MARKET OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

 

LIST OF TABLES

TABLE 1       EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

TABLE 2       EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 3       EUROPE TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 4       EUROPE TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)

TABLE 5       EUROPE MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)

TABLE 6       EUROPE ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)

TABLE 7       EUROPE FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)

TABLE 8       EUROPE ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 9       EUROPE ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

TABLE 10     EUROPE SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)

TABLE 11     EUROPE SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 12     EUROPE OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)

TABLE 13     EUROPE CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)

TABLE 14     EUROPE OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

TABLE 15     EUROPE NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)

TABLE 16     EUROPE NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 17     EUROPE CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)

TABLE 18     EUROPE OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)

TABLE 19     EUROPE ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)

TABLE 20     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 21     HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)

TABLE 22     TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

LIST OF FIGURES

FIGURE 1     PROCESS OF COAGULATION

FIGURE 2     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)

FIGURE 3     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 4     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)

FIGURE 5     EUROPE TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 6     EUROPE TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 7     EUROPE TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)

FIGURE 8     EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)

FIGURE 9     EUROPE ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 10   EUROPE SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)

FIGURE 11   EUROPE SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)

FIGURE 12   EUROPE SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)

FIGURE 13   EUROPE ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 14   EUROPE NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)

FIGURE 15   EUROPE NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)

FIGURE 16   EUROPE ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)

FIGURE 17   PORTER’S FIVE FORCE MODEL

FIGURE 18   EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 19   THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 20   GERMANY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 21   FRANCE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 22   ITALY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 23   SPAIN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

FIGURE 24   REST OF EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. MARKET BY PRODUCTS
    • TOPICAL HEMOSTAT
      • MECHANICAL HEMOSTATS
      • ACTIVE HEMOSTATS
      • FLOWABLE HEMOSTATS
    • ADHESIVE AND TISSUE SEALANTS
      • SYNTHETIC TISSUE SEALANT
        • OXIDIZED REGENERATED CELLULOSE
        • CYANOACRYLATE ADHESIVES
        • OTHER SYNTHETIC TISSUE SEALANTS
      • NATURAL TISSUE SEALANT
        • CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
        • OTHER NATURAL TISSUE SEALANT
      • ADHESION BARRIER PRODUCTS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now